Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
- Status
- TERMINATED
- Phase
- N/A
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace
- Status
- COMPLETED
- Phase
- NA
Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Quality of Life the Danish Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A
Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
- Status
- COMPLETED
- Phase
- PHASE2
Role of CX3CR1-expressing Cells in Hematologic Malignancy
- Status
- UNKNOWN
- Phase
- N/A
Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies
- Status
- COMPLETED
- Phase
- N/A
MMRF Molecular Profiling Protocol
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Institut Paoli Calmettes Multiple Myeloma Database
- Status
- RECRUITING
- Phase
- N/A
Oral ONC201 in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70
- Status
- COMPLETED
- Phase
- PHASE2
Early Patient Access Treatment Use Protocol CA204-220
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance
- Status
- COMPLETED
- Phase
- N/A